XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Operating Activities    
Net income $ 429.6 $ 729.3
Adjustments to reconcile net income to net cash provided by (used for) operations:    
Depreciation 178.9 161.7
Amortization 166.1 176.1
Other intangible assets impairment charge 150.4 0.0
Pension settlement loss (gain) 7.5 30.8
Share-based compensation expense 15.2 20.9
Gain on divestitures – net 9.6 27.2
Other noncash adjustments – net 12.3 11.6
Make-whole payments included in financing activities 7.0 0.0
Changes in assets and liabilities, net of effect from divestitures:    
Trade receivables (30.7) (50.4)
Inventories (131.0) (50.9)
Other current assets 22.5 0.9
Accounts payable (15.2) 142.7
Accrued liabilities (35.8) 88.7
Income and other taxes (14.9) 20.1
Other – net (9.7) 19.7
Net Cash Provided by (Used for) Operating Activities 742.6 1,274.0
Investing Activities    
Additions to property, plant, and equipment (244.5) (198.7)
Proceeds from divestitures – net 130.2 569.3
Other – net (17.6) 48.5
Net Cash Provided by (Used for) Investing Activities (131.9) 419.1
Financing Activities    
Short-term borrowings (repayments) – net 11.7 (82.4)
Proceeds from long-term debt 797.6 0.0
Repayments of long-term debt, including make-whole payments (1,157.0) (700.0)
Capitalized debt issuance costs (10.4) 0.0
Quarterly dividends paid (311.1) (304.8)
Purchase of treasury shares (7.7) (504.1)
Proceeds from stock option exercises 16.2 0.7
Other – net 0.3 0.0
Net Cash Provided by (Used for) Financing Activities (660.4) (1,590.6)
Effect of exchange rate changes on cash (0.3) 7.9
Net increase (decrease) in cash and cash equivalents (50.0) 110.4
Cash and cash equivalents at beginning of period 334.3 391.1
Cash and Cash Equivalents at End of Period $ 284.3 $ 501.5